Tiaoshen Anti-Cancer Protocol, Ovarian Cancer, Insomnia, Shanghai
Summary
A Phase 3 clinical trial (NCT07550205) titled 'Tiaoshen Anti-Cancer Protocol' has been registered on ClinicalTrials.gov for the investigation of ovarian cancer and insomnia. The trial is conducted in Shanghai. ClinicalTrials.gov serves as a public registry for clinical studies, providing basic trial information including conditions studied, location, and registration identifiers.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 12 changes logged to date.
What changed
A new Phase 3 clinical trial has been registered on ClinicalTrials.gov under identifier NCT07550205. The trial studies the Tiaoshen Anti-Cancer Protocol for patients with ovarian cancer who also experience insomnia. The study is conducted in Shanghai.
For patients and healthcare providers, this registry entry indicates an active Phase 3 investigation of an integrative or alternative protocol for ovarian cancer symptom management. Interested parties should consult ClinicalTrials.gov directly for enrollment criteria, investigator details, and study status updates.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.